Form 4: CME Group Director Martin J. Gepsman Acquires Shares Through Stock Plan

CME Group Inc. Director Martin J. Gepsman acquired 532 shares of Common Stock Class A at $273.03 per share, increasing his beneficial ownership to 25,299 shares, as reported in a recent SEC Form 4 filing.

Summary

• Martin J. Gepsman, a Director of CME Group Inc. (CME), acquired 532 shares of Common Stock Class A.
• The transaction occurred on June 25, 2025, at a price of $273.03 per share.
• These shares were granted pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this acquisition, Mr. Gepsman's total beneficial ownership of CME Group Common Stock Class A stands at 25,299 shares.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially as part of a stock plan, is generally viewed positively as it aligns insider interests with shareholders. There are no negative disclosures in this filing.

Positives

• An insider, Director Martin J. Gepsman, acquired additional shares, which can be seen as a positive signal of confidence in the company's future performance.
• The acquisition was part of the CME Group Director Stock Plan, indicating a structured compensation or incentive program for directors.

Negatives

• No explicit negatives are present in this Form 4 filing, which primarily reports an insider transaction.

Risks

• No specific risks are detailed in this Form 4 filing, as its primary purpose is to report an insider transaction.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance, as its purpose is to report a past insider transaction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. CME Group operates in the financial derivatives and exchange industry.

Stakeholder Impact

• Shareholders may view the director's acquisition of shares as a positive signal of confidence in the company's future, potentially influencing investor sentiment.

Next Steps

• This Form 4 filing reports a completed transaction and does not outline future actions or milestones.

Key Dates

Keywords

CME Group Inc., CME, Form 4, Insider Trading, Stock Acquisition, Director Stock Plan, Martin J. Gepsman, Equity Compensation, SEC Filing